MUSC Hollings head and neck team awarded $3.5M to reduce delays in care

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A multidisciplinary team at MUSC Hollings Cancer Center, led by Evan Graboyes, was awarded a $3.5 million grant to test an approach for reducing delays in care for head and neck cancer patients.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents


According to preliminary data from a multi-institution phase III trial led by researchers at MD Anderson Cancer Center, intensity modulated proton therapy achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated radiation therapy as part of chemoradiation treatment for patients with oropharyngeal cancer.